Assignee
LOBSOR PHARMACEUTICALS AB
SE·3 granted patents·26 citations·filing 2015–2018
Top patents by PatentIndex Score
3 records- 0192US10786472B2Pharmaceutical compositions comprising levodopa, a dopamine decarboxylase inhibitor and a COMT inhibitor and method of administration thereofLOBSOR PHARMACEUTICALS AB·Filed 2018·Granted Sep 29, 2020·7 cites·23 claims
- 0289US10071069B2Pharmaceutical compositions comprising levodopa, a dopamine decarboxylase inhibitor and a COMT inhibitor and method of administration thereofLOBSOR PHARMACEUTICALS AB·Filed 2015·Granted Sep 11, 2018·9 cites·17 claims
- 0386US10555922B2Method of treating a dopamine related disorder in a subject by administering levodopa, in combination with a dopamine decarboxylase inhibitor and a catechol-o-methyltransferase inhibitorLOBSOR PHARMACEUTICALS AB·Filed 2016·Granted Feb 11, 2020·10 cites·48 claims
Join the waitlist — get patent alerts
Get an alert when LOBSOR PHARMACEUTICALS AB files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →